KNSA | Kiniksa Pharmaceuticals, Ltd.
Quick infos Trade prices Volume: Market Cap: 1.02B Prev closed: 22.46 Open: 22.6 High: 23 Low: 21.65 52 week low: 10.3 52 week high: 28.67 Dividends: No Dividends Next ER: August 3, 2021 Before Market Opens
Company Profile Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines designed to modulate immunological signaling pathways for patients suffering from debilitating diseases with significant unmet medical need.
Earnings History Date EPS / Forecast Revenue / Forecast August 3, 2021 -0.61 / -0.84677.7M / 4.29MBeat! May 5, 2021 - / -0.6833- / -February 23, 2021 -0.79 / -0.636- / -November 5, 2020 -0.66 / -0.605- / -August 10, 2020 - / -0.63- / -view more
Historical Data Date Price Open High Low Vol Change ER Sep 17, 2021 12.19 12.03 12.50
11.80
979.19K 2.09% Sep 16, 2021 11.94 11.86 11.97
11.55
271.30K -0.08% Sep 15, 2021 11.95 12.04 12.31
11.82
299.20K -1.57% Sep 14, 2021 12.14 12.44 12.46
12.03
241.96K -2.02% Sep 13, 2021 12.39 12.58 12.80
12.09
423.40K -0.08% Sep 10, 2021 12.40 13.02 13.02
12.38
221.47K -3.95% Sep 9, 2021 12.91 12.38 13.24
12.38
298.26K 3.86% Sep 8, 2021 12.43 12.58 12.75
12.22
462.66K -0.96% Sep 7, 2021 12.55 12.30 12.80
12.21
326.01K 1.87% Sep 3, 2021 12.32 12.96 12.96
12.13
307.91K -5.01% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2015 Employees:135 News
Kiniksa wins FDA approval of Arcalyst for pericarditis; shares up 14% after-hours seekingalpha.com Mar 19, 2021 5:29 am Regeneron and Kiniksa sign commercial supply agreement for Rilonacept seekingalpha.com Mar 4, 2021 6:07 am
Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis finance.yahoo.com Mar 2, 2021 8:00 am Can Kiniksa Pharmaceuticals Ltd (KNSA) Stock Rise to the Top of Healthcare Sector Tuesday? investorsobserver.com Feb 25, 2021 9:22 am Kiniksa Pharmaceuticals EPS misses by $0.18 seekingalpha.com Feb 23, 2021 9:08 pm
Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity finance.yahoo.com Feb 23, 2021 8:00 am Flying taxi maker EHang shares rebound 40% after response to short-seller reportdoor.com Feb 18, 2021 9:22 am Warren Buffett's favorite indicator is at a dangerous level, but he just bought these stocks anyway reportdoor.com Feb 18, 2021 9:22 am Where Does Kiniksa Pharmaceuticals Ltd (KNSA) Stock Fall in the Biotechnology Field? investorsobserver.com Feb 18, 2021 9:22 am Brent Oil Passes $65 With US Crisis Now a Global Supply Shock reportdoor.com Feb 18, 2021 9:22 am 3 Top Biotech Stocks With Major Catalysts Approaching nasdaq.com Feb 18, 2021 9:22 am Kiniksa Pharmaceuticals (KNSA) Chairman & CEO Sanj K Patel Sold $1.3 million of Shares finance.yahoo.com Feb 11, 2021 9:22 am BofA's biopharma picks into 2021 set to build with new launches, 'beatable' expectations seekingalpha.com Jan 6, 2021 7:37 am Kiniksa Reports Positive Results of Pericarditis-Drug Trial thestreet.com Oct 26, 2020 10:48 am
New Strong Sell Stocks for January 27th finance.yahoo.com Jan 27, 2021 9:36 am
Kiniksa Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference finance.yahoo.com Jan 4, 2021 4:20 pm Kiniksa's antibody treatment shows clinical benefit in late-stage COVID-19 study seekingalpha.com Dec 23, 2020 3:16 am
Is KNSA A Good Stock To Buy Now? finance.yahoo.com Dec 18, 2020 8:51 am Dosing underway in Kiniksa Pharma's lumpy skin disease study with vixarelimab seekingalpha.com Dec 16, 2020 1:13 am Kiniksa Pharma's KPL-404 shows encouraging action in early-stage study seekingalpha.com Nov 30, 2020 10:58 pm This company doesn't provide a dividend.
Key Persons Talk about Kiniksa Pharmaceuticals, Ltd. below in comments section below. Do you think you'll buy? Do you already have active trades now?
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
